ProfileGDS4718 / 239629_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 85% 80% 69% 84% 84% 64% 65% 71% 82% 81% 81% 87% 64% 61% 66% 82% 72% 70% 62% 88% 77% 78% 75% 83% 86% 66% 87% 74% 82% 52% 70% 74% 81% 80% 59% 66% 67% 77% 74% 70% 75% 71% 76% 62% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.4711585
GSM549102patient 115, normal, homogenized [OPG study]7.7887780
GSM549104patient 119, normal, homogenized [OPG study]6.8750769
GSM549108patient 138, normal, homogenized [OPG study]8.1680684
GSM549119patient 077, normal, homogenized [OPG study]8.317884
GSM549133patient 032, cancer, homogenized [OPG study]6.4234364
GSM549139patient 042, cancer, homogenized [OPG study]6.5183665
GSM549099patient 107, normal, homogenized [OPG study]6.9135971
GSM549109patient 139, normal, homogenized [OPG study]8.0602582
GSM549110patient 046, normal, homogenized [OPG study]7.9173681
GSM549114patient 063, normal, homogenized [OPG study]8.0538381
GSM549122patient 082, normal, homogenized [OPG study]8.6786187
GSM549134patient 033, cancer, homogenized [OPG study]6.4079264
GSM549136patient 036, cancer, homogenized [OPG study]6.1528861
GSM549140patient 044, cancer, homogenized [OPG study]6.5837766
GSM549111patient 047, normal, homogenized [OPG study]8.169882
GSM549113patient 057, normal, homogenized [OPG study]7.1002372
GSM549132patient 031, cancer, homogenized [OPG study]6.9177670
GSM549137patient 038, cancer, homogenized [OPG study]6.2468962
GSM549142patient 047, cancer, homogenized [OPG study]8.5268588
GSM549100patient 110, normal, homogenized [OPG study]7.4071177
GSM549107patient 135, normal, homogenized [OPG study]7.6387578
GSM549115patient 068, normal, homogenized [OPG study]7.4038475
GSM549116patient 072, normal, homogenized [OPG study]8.2823883
GSM549120patient 078, normal, homogenized [OPG study]8.5787286
GSM549131patient 030, cancer, homogenized [OPG study]6.5522766
GSM549118patient 074, normal, homogenized [OPG study]8.7248487
GSM549129patient 027, cancer, homogenized [OPG study]7.3163574
GSM549123patient 088, normal, homogenized [OPG study]8.1273582
GSM549124patient 006, cancer, homogenized [OPG study]5.6551952
GSM549126patient 015, cancer, homogenized [OPG study]6.9082770
GSM549128patient 025, cancer, homogenized [OPG study]7.3336974
GSM549103patient 117, normal, homogenized [OPG study]7.7952181
GSM549117patient 073, normal, homogenized [OPG study]7.8338980
GSM549138patient 041, cancer, homogenized [OPG study]6.0545559
GSM549141patient 045, cancer, homogenized [OPG study]6.6230166
GSM549130patient 028, cancer, homogenized [OPG study]6.638767
GSM549101patient 111, normal, homogenized [OPG study]7.513877
GSM549105patient 128, normal, homogenized [OPG study]7.2114774
GSM549106patient 134, normal, homogenized [OPG study]6.957970
GSM549112patient 048, normal, homogenized [OPG study]7.3095375
GSM549125patient 011, cancer, homogenized [OPG study]6.8971371
GSM549127patient 024, cancer, homogenized [OPG study]7.4892276
GSM549135patient 035, cancer, homogenized [OPG study]6.232362